| Dr Steven A Kamenir, | |
|
319 S Manning Blvd, Suite 203, Albany, NY 12208 | |
| (518) 489-3292 | |
| (518) 453-6286 |
| Full Name | Dr Steven A Kamenir |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 34 Years |
| Location | 319 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255416012 | NPI | - | NPPES |
| 01787035 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | 2073671 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital District Pediatric Cardiology Associates Pc | 2163508466 | 5 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
| Entity Name | Mary Imogene Bassett Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083664221 PECOS PAC ID: 3779488325 Enrollment ID: O20031205000553 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
| Entity Name | Capital District Pediatric Cardiology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407923873 PECOS PAC ID: 2163508466 Enrollment ID: O20080327000184 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven A Kamenir, 319 S Manning Blvd, Suite 203, Albany, NY 12208 Ph: (518) 489-3292 | Dr Steven A Kamenir, 319 S Manning Blvd, Suite 203, Albany, NY 12208 Ph: (518) 489-3292 |
News Archive
3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.
A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 1 days ago
Tamara Jennifer Wrzesinski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1092 Madison Ave, Albany, NY 12208 Phone: 518-525-2445 | |
Dr. Patricia Marie Hopkins, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-0218 Fax: 518-262-4933 | |
Dr. Kallanna Manjunath, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 920 Lark Dr, Albany, NY 12207 Phone: 518-465-4771 Fax: 518-242-4784 | |
Lisa Benay Kamerling, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1092 Madison Ave, St. Peter's Health Care For Children, Albany, NY 12208 Phone: 518-525-2445 Fax: 518-475-7069 | |
Michael T Colon, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd, Suite 203, Albany, NY 12208 Phone: 518-489-3292 Fax: 518-453-6286 | |
Sarah Kathleen Klaiber Sokil, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 103 Great Oaks Blvd, Albany, NY 12203 Phone: 518-464-1392 | |
Anita Catherine Saldanha, MD PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Department Of Pediatrics, Albany, NY 12208 Phone: 518-262-3095 |